ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 108 filers reported holding ARGENX SE in Q3 2018. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $9,766,000 | -53.6% | 27,889 | -84.9% | 1.12% | -54.8% |
| Q3 2019 | $21,041,000 | -29.4% | 184,631 | -12.2% | 2.48% | -15.1% |
| Q2 2019 | $29,784,000 | -11.8% | 210,372 | -22.2% | 2.93% | -35.1% |
| Q1 2019 | $33,775,000 | +21.2% | 270,548 | -6.8% | 4.52% | +7.4% |
| Q4 2018 | $27,878,000 | +36.5% | 290,181 | +7.7% | 4.20% | +195.0% |
| Q3 2018 | $20,426,000 | +21.9% | 269,325 | +33.1% | 1.42% | +21.8% |
| Q2 2018 | $16,762,000 | +25.5% | 202,293 | +21.9% | 1.17% | +10.9% |
| Q1 2018 | $13,354,000 | +139.6% | 166,011 | +88.1% | 1.06% | +193.9% |
| Q4 2017 | $5,573,000 | – | 88,269 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |